CHOP Cancer Researchers Win 2021 AACR Team Science Award miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Laura X. Vargas, PhD, MSW, MPA, Vice-Provost post-doctoral fellow at the Penn Injury Science Center at Penn Nursing and lead author of the study.. view more
Credit: Laura Vargas
PHILADELPHIA (April 8, 2021) - Many factors, including need, affect healthcare use. Strategies geared to enhancing the provision and access to healthcare must consider the various mechanisms that contribute to healthcare need and use. Until now, the mechanism of violence and its impact on both health and healthcare use has not been investigated.
A new study from the University of Pennsylvania School of Nursing (Penn Nursing) is one of the first to examine the association between violence exposure and healthcare service utilization in Mexico. Results are published in the
email article
Since the early days of the pandemic, researchers have been trying to use old drugs for new tricks, raising hopes and spurring controversy. Some of these, like hydroxychloroquine, turned out to be flops, while others are still debated. Recently, another old drug called fluvoxamine has come onto the scene.
MedPage Today explores how the old antidepressant has made its way to the COVID spotlight.
Fluvoxamine and the COVID Early Treatment Fund
Fluvoxamine is the poster child of the COVID-19 Early Treatment Fund (CETF). According to its founder, serial tech entrepreneur Steve Kirsch, CETF was started in April 2020 in order to fund drug repurposing research to find the fastest and most cost-effective early outpatient treatments for COVID-19. Kirsch told
How long is the vaccine effective is one of many questions Delaware Valley residents are asking
Questions remain regarding the COVID vaccine, including how long does the vaccine last?
Dawn Timmeney asks an expert in immunology the many questions people in the Delaware Valley are asking about the COVID vaccine
UNIVERSITY CITY - As states across the region expand COVID vaccine eligibility, questions regarding the vaccine remain. One of the biggest questions on people’s minds is just how long do the vaccines last. Six months is kind of like the floor here. That is the minimum, Doctor John Wherry, Director of the Institute of Immunology at University of Pennsylvania Perelman School of Medicine, said. Six months is about the longest data we have from a reasonable sized number of people we can draw conclusions.
Some blood pressure meds may increase, while others lower, heart risks in people with HIV sfgate.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sfgate.com Daily Mail and Mail on Sunday newspapers.